|
|  Custom CD of patents similar to US4705501 : Bi-directional, anti-reflux vascular access system - $19.95 |
| United States Patent | 4705501 |
| Link to this page | http://www.wikipatents.com/4705501.html |
| Inventor(s) | Wigness; Bruce D. (Minneapolis, MN);
Anderson; Michael H. (Minneapolis, MN) |
| Abstract | An implantable access system for infusion of liquids into a body or
aspiration of liquid samples from the body. The system includes a
septum/manifold (16) and catheter (10) connected thereto, both of specific
design. The septum/manifold includes a pair of manifold chambers (24, 25)
each closed with a self-sealing septum (20, 22) and each having a first
access entry (19) and second access entry (26, 27) (35, 36). The catheter
includes a pair of concentric inner and outer tubes (11, 12). The inner
tube (11) is collapsible and closed at its distal end. The outer tube (12)
closely engages the inner tube and defines a catheter lumen (28) therewith
when the inner tube is collapsed by evacuation. The inner and outer tubes
are joined together longitudinally over a small portion of the
circumference of the inner tube. |
| |
|
Title Information  |
|
|
|
|
|
Drawing from US Patent 4705501 |
|
|
Bi-directional, anti-reflux vascular access system |
|
|
|
|
|
| Publication Date |
November 10, 1987 |
|
|
|
|
|
| Filing Date |
April 12, 1982 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title Information  |
|
|
References  |
|
|
| *references marked with an asterisk below are user-added references |
|
U.S. References |
|
|
|
|
|
|
U.S. References |
|
|
Foreign References |
|
|
|
|
|
|
Foreign References |
|
|
Other References |
|
|
|
|
|
|
Other References |
|
|
|
|
|
References  |
|
|
|
|
|
|
|
|
|
|
|
Public's "Guesstimation" of Royalty Value
| |
|
|
|
|
|
|
|
|
|
|
|
|
Market Review  |
|
|
Technical Review  |
|
|
Claims  |
|
|
We claim:
1. A bi-directional, anti-reflux vascular access system comprising:
(A) an implantable septum/manifold comprising:
(1) a housing;
(2) a pair of manifold chambers within said housing;
(3) first entry means to said chambers,
(4) a self-sealing septum closing the first entry means to each of said
chambers, and
(5) separate second entry means to each of said chambers, and
(B) an implantable catheter joined to said septum/manifold and comprising:
(1) an inner collapsible flexible tube closed at the distal end, and
(2) an outer flexible tube of substantially the same length as the inner
tube closely embracing the outer wall of the inner tube,
(a) said outer tube being open at both ends,
(b) the inside wall of said outer tube normally engaging the outside wall
of the inner tube in a separate non-adherent relationship over a
substantial portion of the circumference of the inner tube, forming a
normally closed passage between the tubes, and
(c) the inner and outer tubes being joined together longitudinally over a
small portion of the circumference of the inner tube,
the inside tube of said catheter being in direct fluid communication with
the second entry means of one of said chambers, and the normally closed
passage between the tubes being in direct fluid communication with the
second entry means of the other of said chambers.
2. An access system according to claim 1 wherein said chambers of the
septum/manifold are disposed in vertically stacked relation sharing a
common first entry means and separated by one of said septa.
3. An access system according to claim 1 wherein said chambers of the
septum/manifold are disposed in closely spaced apart side-by-side relation
and have separate spaced apart first entry means.
4. An access system according to claim 1 wherein said passage formed
between the closely embracing nonadherent wall portions of the tubes
extends around about 50 to 95% of the circumference of the inner tube.
5. An access system according to claim 1 wherein:
(A) the closed distal end of the inner tube is pinched together and the
inside wall surfaces are laminated to each other, and
(B) the end of the catheter is cut at an oblique angle with the laminated
side forming the distal-most edge of the bevel.
6. An implantable bi-directional, anti-reflux catheter comprising:
(A) an inner collapsible flexible tube closed at the distal end, and
(B) an outer flexible tube of substantially the same length as the inner
tube closely embracing the outer wall of the inner tube,
(1) said outer tube being open at both ends,
(2) the inside wall of said outer tube normally engaging the outside wall
of the inner tube in a separate non-adherent relationship over a
substantial portion of the circumference of the inner tube, thereby
forming a normally closed passage between the tubes, and
(3) the inner and outer tubes being joined together longitudinally over a
small portion of the circumference of the inner tube.
7. A catheter according to claim 6 wherein said passage formed between the
closely embracing non-adherent portions of the tubes extends around about
50 to 95% of the circumference of the inner tube.
8. An implantable septum/manifold comprising:
(A) a housing having a central cylindrical passage in its lower portion and
a connecting central passage of smaller diameter through its top wall,
(B) a cup-like plug in the bottom end of said central passage, said plug
having a cylindrical recess in its upper surface forming a manifold
chamber,
(C) a first entry means to said manifold chamber and a self-sealing
resilient septum seated on the upper surface of the cup-like plug and
closing the entry means,
(D) a tightly fitted cylindrical collar seated upon said septum, the
passage within said collar forming a further manifold chamber,
(E) a first entry means to said further manifold chamber and a further
self-sealing septum disposed between the top surface of said collar and
the inside top wall of the housing closing said entry means, and
(F) separate second entry means to each of said chambers,
said housing, plug and collar being formed from a rigid, inert, non-toxic,
bio-compatible material for implantation in a living body.
9. An implantable bi-directional, anti-reflux catheter comprising:
(A) an inner collapsible flexible tube closed at the distal end by being
pinched together with the inside wall surfaces laminated to each other,
and
(B) an outer flexible tube of substantially the same length as the inner
tube closely embracing the outer wall of the inner tube,
(1) said outer tube being open at both ends,
(2) the inside wall of said outer tube normally engaging the outside wall
of the inner tube in a separate non-adherent relationship over a
substantial portion of about 50 to 95% of the circumference of the inner
tube, thereby forming a normally closed passage between the tubes,
(3) the inner and outer tubes being joined together longitudinally over a
small portion of about 5 to 50% of the circumference of the inner tube,
and
(4) the end of the catheter being cut at an oblique angle with the
laminated closed distal end of the inner tube forming the distal-most edge
of the bevel.
10. An implantable septum/manifold comprising:
(A) a rigid housing formed from an inert non-toxic, biocompatible aterial
for implantation in a living body,
(B) a pair of separate closed end cylindrical manifold chambers recessed
within the same surface of said housing and disposed in closely laterally
spaced apart side-by-side relation,
(C)separate spaced apart first entry means to said chambers in the form of
the open ends of said chambers,
(D) a separate septum closing the first entry means to each of said
chambers, each comprising a disc of self-sealing resilient inert,
non-toxic, biocompatible material of diameter greater than the diameter of
the chamber and seated in an annular recess adjacent the open end of the
chamber,
(E) separate second entry means to each of said chambers in the form of
passages within the housing entering the chambers adjacent to the closed
ends thereof, and adapted to communicate with a single common passage int
a catheter, and
(F) means for securing the septum/manifold in place when implanted. |
|
|
|
|
Claims  |
|
|
Description  |
|
|
FIELD OF THE INVENTION
1. Background of the Inventon:
This invention relates to a bi-directional, anti-reflux vascular access
system comprised of a totally implantable intravascular catheter and
septum/manifold. The catheter provides an access for either drug infusion
or blood sampling. It is designed to prevent plugging by blood components
during long periods of dormancy. This is accomplished by constructing the
catheter lumen so that it can be shifted into either a "dormant" or an
"active" configuration. Total implantability is achieved by attaching this
catheter to a specially designed bichambered septum/manifold assembly.
Vascular catheters are commonly used in medicine and occasionally used in
animal research. Applications for these catheters include infusion of
parenteral fluids, single-needle hemodialysis and repeated arterial and
venous blood sample collection.
2. The Prior Art:
Of the currently available intravascular catheters, the most commonly used
type is made up of a plastic or rubber tube with a hub for syringe
connection at one end. Implantation of these catheters results in the hub
end being on the outside of the body with the rubber or plastic tube
passing transcutaneously into the subcutaneous tissue and then into the
blood vessel. When these catheters are not being used, the lumen is filled
with a sterile solution (sometimes containing an anti-coagulant, e.g.
heparinized saline) and a plug is placed in the hub. The routine daily
care that is required of these catheters includes flushing the lumen with
sterile solutions in order to prevent plugging with blood clots, and
scrupulous cleaning of the skin in the area around the catheter-skin
interface in order to avoid infection. In using these catheters in
research involving experimental animals, the additional complication
frequently arises of an animal removing or severing the catheters, making
this work very difficult.
A more recent catheter design is one in which the rubber tube is connected
to and communicates with an implantable plenum containing a septum. At the
time of canulation, this type of catheter is completely implanted with the
septum lying directly under the surface of the skin. In order to infuse
solutions through these catheters, a hypodermic needle is pierced through
the skin and septum and into the plenum. Then, a syringe filled with the
solution to be infused is connected to the hub of the needle and injected.
Although this type of catheter does not require daily care for the
prevention of infection, the lumen can very easily become plugged with
blood clots which are subsequently flushed into the cardiovascular system.
This type of catheter is not useful in situations requiring aspiration of
blood since the diameter of the lumen is kept small in order to minimize
the diffusion of blood components. This reduces the probability of the
catheter becoming irreversibly plugged by a clot too large to dislodge and
furthermore minimizes the size of the thromboemboli.
A form of long term implantable catheter having a check valve tip for
unidirectional flow, designed to prevent plugging of the lumen with
particulates, is disclosed in a co-pending Dorman application Ser. No.
245,379, filed Mar. 19, 1981, of common ownership with the present
application.
The catheter according to the present invention is also designed to avoid
the hazards and inconvenience common to using the catheters currently
available. By mounting the catheter tube to an implantable septum, the
risk of septicemia is greatly reduced and the need for daily care is
eliminated. The possibility of blood clotting in the catheter lumen during
periods of dormancy is eliminated by designing the lumen so that it has
both an open and a closed mode.
SUMMARY OF THE INVENTION
Broadly stated, the bi-directional, anti-reflux vascular access system
according to the present invention comprises a dual-chambered implantable
septum/manifold and implantable catheter connected thereto. The
septum/manifold includes a housing enclosing a pair of manifold chambers.
First entry means are provided to the chambers. A self-sealing septum
closes the first entry means to each of the chambers. Separate second
entry means are also provided to each of the chambers for connection to
the catheter.
The catheter includes inner and outer generally concentric flexible tubes
of substantially the same length. The inner tube is collapsible and closed
at the distal or downstream end. The outer tube is open at both ends and
embraces the outer wall of the inner tube. The inside wall of the outer
tube normally engages the outside wall of the inner tube in a separable
non-adherent relationship over a substantial (e.g. about 50 to 95%)
portion of the circumference of the inner tube. This forms a normally
closed passage between the tubes when the catheter is in a dormant or at
rest state. The inner and outer tubes are joined together longitudinally
over a small portion (e.g. about 5% or more) of the circumference of the
inner tube.
The proximal or upstream end of the inner closed-end collapsible tube is
connected to one of the chambers of the septum/manifold through which
suction may be applied to collapse the inner tube and open the normally
closed passage between the inner and outer tubes. That normally closed
passage is connected to the other chamber of the septum/manifold through
which liquid may be infused into the blood stream or blood may be
aspirated.
The chambers of the septum/manifold may be disposed in vertically stacked
relation sharing a common first entry means and separated by one of the
septa. Alternatively, the chambers may be disposed in closely spaced apart
side-be-side relation with separate spaced apart first entry means and
septa. In its simplest form the catheter may be in the form of concentric
tubes tightly fitted together and longitudinally bonded along a narrow
stripe.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention is illustrated in the accompanying drawings in which
corresponding parts are identified by the same numerals and in which:
FIG. 1 is an elevation, partly in section to show details of construction,
of an intra-vascular catheter forming part of the access system of the
present invention;
FIG. 1A is a distal end view of the catheter.
FIG. 2 is a transverse section on the line 2--2 of FIG. 1 and in the
direction of the arrows, showing the catheter in its dormant state;
FIG. 3 is an elevation in section of one form of septum/manifold forming
part of the access system of the invention;
FIG. 4 is an elevation in section of another form of septum/manifold;
FIG. 5 is a fragmentary elevation in section, on an enlarged scale, showing
the connection between catheter and septum/manifold;
FIG. 6 is a transverse section on line 6--6 of FIG. 5 and in the direction
of the arrows;
FIG. 7 is a transverse section, similar to FIG. 2, through the catheter in
its active state;
FIG. 8 is a transverse section, similar to FIG. 2, showing an alternative
form of catheter;
FIG. 9 is a top plan view of a further alternative form of septum/manifold;
FIG. 10 is a section on the line 10--10 of FIG. 9 and in the direction of
the arrows, and
FIG. 11 is a longitudinal section on an enlarged scale of the connection
between catheter and septum/manifold.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring now to the drawings, and particularly to FIGS. 1 and 2, there is
shown one form of catheter according to the present invention. The
catheter, indicated generally at 10, may be of any desired length
appropriate to the particular use to which it is to be put. The catheter
comprises a central inner tube 11 of circular cross-section formed from
any of a large number of flexible, inert, non-toxic, bio-compatible rubber
or synthetic rubber-like materials. A preferred material is medical grade
silicone rubber tubing. The inner tube 11 is at least partially surrounded
by a closely fitting outer tube 12 preferably of the same material and of
substantially the same length as the inner tube. The inside wall surface
of outer tube 12 engages the outside wall surface of inner tube 11 in
face-to-face contact but in a non-adherent relationshsip over most (e.g.
50 to 95%) of the circumference of the inner tube. In the embodiment
shown, the outer tube 12 is slit along its entire length and about one
third of its circumference is removed. Then the slitted outer tube 12 is
slipped over the intact tube and is permanently mated into place by
dipping or lathing on a thin layer 13 of an adhesive coating material,
such as silicone rubber adhesive. This sealing coat or layer 13 fills the
space between the split edges of the outer tube 12 and bonds the inner and
outer tubes together along those edges. This leaves the tubes unbonded
over about two thirds of the circumference of the inner tube. As explained
in detail hereinafter, in use the inner tube of the catheter is collapsed
and the space between the inner and outer tubes becomes the lumen of the
catheter.
After assembly of the inner and outer tubes, the distal or downstream end
of the inner tube 11 is pinched down and permanently laminated to itself
over a distance of about 1/2 inch (1.27 cm) at 14. This forms a blind
chamber 15 within the inner tube. The tip of the catheter is cut off at an
oblique angle with the laminated side forming the distal-most edge of the
bevel. As shown in FIG. 1A, the laminated end of the inner tube assumes a
dimple-like configuration, as is assumed by the inner tube upon
evacuation, as hereinafter explained.
Referring now to FIG. 3 there is shown one form of septum/manifold
subassembly, indicated generally at 16. The septum/manifold is intended
for implantation under the skin. It includes a housing 17 having a central
cylindrical passage 18 in its lower portion and a connecting central
passage 19 of smaller diameter through its top wall. A first self-sealing
septum 20 is seated in passage 18 immediately adjacent to passage 19. A
tightly fitting collar 21 is seated on septum 20. A second septum 22 is
seated upon collar 21 and a cup-like needle stop plug 23 is seated upon
the second septum. Housing 17, collar 21 and plug 23 are formed from a
rigid inert, non-toxic, biocompatible, millable material. Polycarbonate
and polyether sulfane are exemplary of such materials. The septa 20 and 22
are preferably silicone rubber. The assembled stacked septum/manifold is
clamped together and the parts are fused together, i.e., polycarbonate
parts with methylene dichloride.
The space between septa 20 and 22 forms a first manifold chamber 24 and the
space within cup-like plug 23 forms a second manifold chamber 25. Passage
19 provides a first common access entry to both manifold chambers for a
hypodermic needle or the like. Access to the manifold chambers is achieved
by drilling two parallel holes perpendicular to the axis of symmetry. Two
tightly fitting stainless steel tubes 26 and 27 are inserted into the
appropriate holes and then bonded with methylene dichloride. Tubes 26 and
27 thus provide separate second access entries to the manifold chambers.
The smaller steel tube 26 is then bent in two places so that in its final
configuration it is parallel to and snug against the larger steel tube 27.
An alternative form of septum/manifold 16A is shown in FIG. 4. Manifold
chambers 24A and 25A are formed in housing 17A disposed in closely spaced
side-by-side relation. The chambers are closed by means of septa 20A and
22A, respectively. Separate first access entries 19A and 19B are provided
to the respective chambers and separate second access entries in the form
of tubes 26A and 27A are provided.
As shown in FIGS. 5 and 6, the two subassemblies are connected together as
follows: The proximal end of the catheter tube 10 is attached to the
septum/manifold 16 by inserting the small diameter steel tube 26 into the
inner silicone rubber tube 11 (the blind chamber 15) and inserting the
larger diameter steel tube 27 in between the two concentric silicone
rubber tubes 11 and 12 (the catheter lumen). This joint may be wrapped
with silk suture and bonded with silicone rubber adhesive.
An alternative form of catheter 10A is shown in FIG. 8. The inner tube 11A
is performed. The outer surface of inner tube 11A is coated over about 50
to 95% of its circumference with a thin layer 30 of non-stick or
non-adherent material relative to the material of which the catheter tubes
are formed. For example, a thin layer of tetrafluoroethylene (Teflon) is
applied to the outer wall of silicone rubber tubing. A one molecule thick
layer may be applied as, for example, by plasma coating techniques. The
partially coated tubing is dipped in silicone rubber to form an outer tube
12A surrounding the inner tube but non-adherent thereto over the coated
area. A bond 31 is formed between the inner and outer tubes over the
uncoated area. The inner tube 11A may be collapsed by suction forming a
lumen between the inner and outer tubes. While the inner and outer tubes
should be bonded along their lengths to prevent "snaking" of the inner
tube which might block the lumen, this bonding need not be continuous.
A further alternative form of septum/manifold 16B is shown in FIGS. 9
through 11. Manifold chambers 24B and 25B are formed in housing 17B
disposed in closely spaced side-by-side relation. The chambers are closed
by means of septa 20B and 22B, respectively. Separate first access entries
19C and 19D are provided to the respective chambers. Separate second
access entries are provided as follows. A chamber 32 is provided in the
bottom of housing 17B communicating with chambers 24B and 25B. An insert
33 of the same size and geometrical configuration as chamber 32 is
provided at the proximal end of the catheter. The insert is desireably
formed of the same material and integral with the catheter, i.e., silicone
rubber.
Insert 33 has a central passage 34 into which the end of the catheter is
fitted and sealed. A radial passage 35 extends through the insert body and
through the walls of inner and outer catheter tubes 11 and 12 to connect
the blind chamber 15 with septum/manifold chamber 24B. A further
diametrically opposite radial passage 36 extends through the insert body
and through the wall of the outer catheter tube only, to connect the
catheter lumen (28, FIG. 7) with septum/manifold chamber 25B. The insert
33 is held in place by a base plate 37 secured to the housing 17B. The
base plate is desireably provided with suture holes 38 for securing the
septum/manifold when implanted.
IMPLANTATION
The vascular access system is implanted using standard surgical techniques.
Proper installation results in the catheter being threaded into the
desired blood vessel and the manifold being secured in the subcutaneous
tissue with the septa facing the skin. After implantation, the vascular
access is maintained in the dormant state as shown in FIG. 2 in which the
blind chamber 15 is filled with a fluid (usually normal saline, although a
radio-opaque dye and air have also been used). The catheter lumen, the
space between the inner and outer tubes, is closed.
OPERATIONS
There are three general operational steps involved in the use of the access
system. First the partition formed by the collapsible portion of the wall
of inner tube 11 or 11A is shifted from the dormant to the active state,
as shown in FIG. 7, opening the lumen 28 for passage of liquid. Second,
either the aspiration or infusion operation is carried out. Finally the
partition is shifted back to the dormant state.
In order to shift the partition from the dormant to the active state, a
needle attached to a syringe is inserted through the septum 20, 20A or 20B
and into the plenum 24, 24A or 24B which communicates through steel tube
26 or 26A or passage 35 with the blind chamber 15 of the catheter. The
fluid is then aspirated from the blind chamber and into the syringe.
Evacuation of the blind chamber causes the partition to move towards the
common wall of the catheter and consequently opens the lumen 28 of the
catheter.
Next, an appropriately sized syringe attached to an appropriately sized
needle is inserted through the septum 22, 22A or 22B and into the plenum
25, 25A or 25B which communicates through steel tube 27 or 27A or passage
36 with the catheter lumen 28 and either sample aspiration or infusion may
be performed.
Following each use of this vascular access system it is important that the
catheter lumen is flushed of any blood components. Towards the end of the
catheter flushing procedure the partition is simultaneously shifted to the
dormant position by slowly filling the blind chamber with a volume of
fluid equivalent to that which was previously aspirated during the
activation step. This volume is such that it completely displaces the
lumen of the catheter by shifting the partition away from the common wall
so that in its final position it seals tightly against the opposite wall.
FIGS. 2 and 7 show the two configurations of the partition.
The catheter tube may have widely varying dimensions dependent upon the
particular application to which it is to be put. In one exemplary catheter
the inner tube 11 and outer tube 12 were constructed from two identical
silicone rubber tubes with inner diameters of 0.058 inches (0.147 cm) and
outer diameters of 0.077 inches (0.196 cm) for a wall thickness of 0.0095
inches (0.024 cm). The initial length of these tubes is about 1 to 2
inches (2.54 to 5 cm) longer than the final desired length. The sealing
coating or layer 13 is about 0.015 inch (0.038 cm). The smaller steel tube
26 is 25 gauge, about 0.02 inch (0.05 cm) O.D. and the larger tube is 15
gauge, about 0.073 inch (0.185 cm) O.D.
For aspirating the fluid from the blind chamber 15 a 1 cc syringe with a 25
gauge Huber point needle has been used. An appropriately sized syringe
fitted with a 20 gauge Huber point needle has been used for infusion and
aspiration. The overall dimensions of the septum/manifold of FIG. 3, in
one exemplary form, were 0.94 inch (2.38 cm) by 1.75 inches (4.45 cm).
Orientation of the system in use is variable. Accordingly, any references
to upper, lower, top, bottom, vertical, etc. relate only to the
orientation shown in the drawings.
It is apparent that many modifications and variations of this invention as
hereinbefore set forth may be made without departing from the spirit and
scope thereof. The specific embodiments described are given by way of
example only and the invention is limited only by the terms of the
appended claims.
* * * * *
|
|
|
|
|
Description  |
|
|
|
|
|